Skip to content
Aperlena
Language:

Romania - Antineoplastics - Framework agreement for the supply of antineoplastics

Original România - Antineoplazice - Acord-cadru furnizare ANTINEOPLAZICE

Awarded Contract award No deadline published
Watch this tender

Bidding is closed. An award or a correction on this notice: an email when the register sees it. Log in

  1. Published
  2. Awarded pending

Summary

Machine-generated summary

The Cluj-Napoca Municipal Clinical Hospital awarded a framework supply contract for antineoplastic medicines, divided into six lots according to the award documentation. Products named include avelumab concentrate for solution for infusion 20 mg/ml - 10 ml (200 mg), folinic acid (calcium folinate) solution for injection/infusion 10 mg/ml, durvalumab concentrate 50 mg/ml, doxorubicin concentrate 2 mg/ml, pegylated liposomal doxorubicin 2 mg/ml, and pembrolizumab concentrate 25 mg/ml - 4 ml (100 mg). Winners were Alliance Healthcare Romania, Farmexim S.A., Dr.MAX, Merck Romania S.R.L. and Compania Nationala Unifarm. The awarded value was EUR 1,880,040.53 against an estimated value of EUR 13,171,073.78.

Description

Achizitie ANTINEOPLAZICE 6 loturi conform caiet sarcini-anexa nr.1. Autoritatea contractanta va raspunde in mod clar si complet tuturor solicitarilor de clarificari/informatiilor suplimentare in a 10-a zi inainte de termenul limita stabilit pentru depunerea ofertelor. Numar zile pana la care se pot solicita clarificari inainte de data limita de depunere a ofertelor/candidaturilor: 18 AVELUMABUM CONC. PT. SOL. PERF 20mg/ml-10 ml (200mg) CANT MAX AC: 3200/FL CANT MAX CS: 80/FL; CALCII FOLINAS sol inj/perf 10 mg/ml-flacon 10 ml CANT MAX AC: 8000/FL CANT MAX CS: 200/FL; DURVALUMABUM conc pt sol perf 50 mg/ml fl a 10 ml (500 mg) CANT MAX AC: 1200/FL CANT MAX CS: 30/FL; DOXORUBICINUM conc pt sol perf 2mg/ml- fl 50 ml cu 100 mg CANT MAX AC: 800/FL CANT MAX CS: 20/FL; DOXORUBICINUM( lipozomală polietilenglicată) 2 mg/ml conc. pt. sol. perf.-fl 10ml CANT MAX AC: 120/FL CANT MAX CS: 3/FL; PEMBROLIZUMABUM conc.pt.sol.perf 25mg/ml-4ml (100mg) CANT MAX AC: 4000/FL CANT MAX CS: 80/FL

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 2 weeks ago

View the official notice

More from this buyer

Full buyer profile

4 open tenders right now

Recent awards

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€10,244,088
9,866 open across Europe right now 29% above sector average
Buyer track record on Aperlena
114 notices tracked · 98 awarded
€70,307,072 in awarded contracts

Never miss a tender like this

276 new notices in Medical equipment & pharmaceuticals in Romania in the last 7 days. Get an email when new ones appear. Free.

Set up my alert
Source

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Jump to the search box
?
Show these shortcuts
Esc
Close